Rising Hypertensive Disorders of Pregnancy: Global Risks

Obstetricians worldwide face an alarming surge in hypertensive disorders of pregnancy. Recently, extensive registry evaluations revealed a 74% increase in maternal hypertension rates over the past decade. Consequently, clinicians must recognize these rising numbers and implement proactive maternal health interventions early in antenatal care.

Trends in Hypertensive Disorders of Pregnancy

A nationwide cross-sectional study analyzed more than 33 million live births between 2016 and 2024. The investigators found that age-standardized rates climbed from 62.7 to 109.1 per 1,000 live births. Furthermore, the average annual percent change reached 7.2% across the study period. In addition, significant disparities persisted across racial and ethnic cohorts, highlighting uneven maternal health burdens.

Underlying Drivers and Clinical Risk Factors

Several metabolic and demographic factors explain this substantial epidemiological shift. First, increasing maternal age contributes markedly to vascular stiffness and elevated baseline blood pressure. Moreover, rising rates of pre-pregnancy obesity and gestational diabetes exacerbate placental endothelial dysfunction. Therefore, obstetric teams must identify high-risk women during their initial booking visits.

Actionable Strategies for Antenatal Management

Early screening protocols significantly improve both maternal and perinatal outcomes. Specifically, doctors should initiate low-dose aspirin before 16 weeks of gestation for patients with moderate to high risk. In addition, routine home blood pressure monitoring empowers patients and detects rapid blood pressure elevations. Ultimately, standardized clinical pathways prevent severe maternal morbidity and reduce intensive care admissions.

Frequently Asked Questions

Q1: What are the main types of hypertensive disorders of pregnancy?

Hypertensive disorders include chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. Additionally, patients can develop preeclampsia superimposed on pre-existing chronic hypertension.

Q2: Why are rates of hypertensive disorders increasing globally?

Rising maternal age, pre-pregnancy obesity, and chronic cardiometabolic diseases primarily drive these increasing trends. Furthermore, improved diagnostic vigilance and broader screening definitions also capture more cases.

Q3: How can clinicians prevent preeclampsia in high-risk patients?

Clinicians recommend low-dose aspirin daily starting between 12 and 16 weeks of gestation. Moreover, adequate calcium supplementation and regular blood pressure monitoring optimize maternal safety.

References

1. Anguzu R et al. Trends in Hypertensive Disorders of Pregnancy Rates by Race and Ethnicity in the United States, 2016-2024. Obstet Gynecol. 2026 Oct 06. doi: 10.1097/AOG.0000000000006445. PMID: 42837632.
2. Sengodan SS, Sreeprathi N. Prevalence of hypertensive disorders of pregnancy and its maternal outcome in a tertiary care hospital, Salem, Tamil Nadu, India. Int J Reprod Contracept Obstet Gynecol. 2020;9(1):262-266.
3. Dzakpasu S, Nelson C, Darling EK, et al. Trends in rate of hypertensive disorders of pregnancy and associated morbidities in Canada: a population-based study (2012–2021). CMAJ. 2024;196(26):E896-E905.
4. World Health Organization. WHO recommendations on prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2011.